Background and aim: In a previous report, when hypertension (HT) overlapped on hypertrophic cardiomyopathy (HTHCM), the decreased survival rate was associated with higher NYHA classes. The study concerned only elderly patients and therefore we decided to extend it by: (1) assessment of the frequency and age-distribution of HTHCM in HCM population; and (2) the comparison of NYHA class between HTHCM and HCM both in younger and older patients. Patients and methods: We retrospectively viewed 123 HCM patients with regard to the presence of hypertension as a concomitant disease. The HTHCM and HCM patients were compared with regard to NYHA functional classes within younger (Ͻ50years of age) and older (Ͼ50 years of age) subgroups. Results: Of the 123 HCM patients, 24 (19.5%) had asso-
Introduction
In a recent population-based study, 1 the elderly patients with hypertrophic cardiomyopathy and concomitant hypertension (HTHCM) represented a subset at higher risk for cardiac death, with an overall decreased survival rate. The NYHA functional class at presentation was significantly higher in those elderly HTHCM patients as compared to patients with only HCM. 1 Multivariate analysis revealed NYHA functional class to be associated with a poor prognosis. In the face of the detrimental overlap of hypertension on HCM, the clarification of the following issues seems important: (1) the frequency and age-distribution of HTHCM in the HCM population; and (2) the comparison of NYHA class status between HTHCM and HCM both in younger and older patients. We decided to study these problems in HCM patients referred to our tertiary centre, who complemented the above-mentioned population-based subset of the broad spectrum of this disease. 
Patients and methods
We reviewed the records of 123 patients with HCM from our two institutions. Each patient met the diagnostic criteria for HCM previously described, 2,3 ie, a hypertrophied and non-dilated left ventricle not associated with another cardiac or systemic disease that could produce the magnitude of left ventricular hypertrophy present. The systemic hypertension defined as blood pressure Ͼ140/90 mm Hg was recognised as concomitant to HCM disease in 24 patients (14 men and 10 women, age range from 18 to 77 years). The mean values of systolic and diastolic blood pressure were 163 ± 11/95 ± 9 mm Hg. The age and NYHA class were analysed from patients' records at presentation. Both HTHCM and HCM patient subsets were subdivided into two groups as follows: group I consisted of younger patients Ͻ50 years of age and group II comprised older patients Ͼ50 years of age.
Statistical analysis
All results are expressed as mean values ± SD. Comparison of variables between the two groups was accomplished using Student's t-test.
Results
Of the 123 HCM patients 24 (19.5%) had associated hypertension. In younger patients this proportion was maintained (15.7%), while in older patients the percentage of HTHCM significantly increased to 38%. In younger patients, the mean values of the NYHA class were significantly higher in HTHCM in comparison to HCM patients (Table 1 ). In older patients this NYHA class difference narrowed and became insignificant (Table 1) .
Discussion
A recent report 1 as a first population-based study of the natural history of HCM revealed a discrepancy in survival between HCM and HTHCM patients. The annual risk of cardiac death was 0.7% for HCM and there was no significant difference in overall survival compared with an age-and sex-matched population. This is in contrast to the poor prognosis among patients with HTHCM, in whom risk of cardiac death was increased to 5% per year. Higher mean NYHA class at presentation (1.96 in HTHCM vs 1.30 in HCM) was associated with a decreased survival in follow-up. 1 The above-mentioned study 1 concerned elderly patients. In the face of such a detrimental influence of hypertension overlapping on HCM, we complemented and explored this issue extending the analysis to younger patients. In our patients the mean value of the NYHA class was higher in HTHCM in comparison to HCM only in younger patients, whereas in older patients functional status was similarly deteriorated in both HTHCM and HCM subsets. In comparison to a previous population-based study, 1 our patients presented with higher NYHA class in all analysed groups which was probably due to the fact that more symptomatic patients were referred to our tertiary assessing only elderly patients revealed that the frequency of hypertension as a concomitant disease to HCM was high and ranged from one-third to two-thirds of HCM patients studied. To our knowledge, in the subset of younger patients with HCM, the occurrence and frequency of concomitant hypertension has not been studied. In our study, over one-third of older HCM patients had concomitant hypertension, while among younger patients coexisting hypertension was recognised in 15.7% of HCM patients. This percentage is not marginal and younger HTHCM patients were more functionally deteriorated than patients with only HCM. Therefore it seems important to verify if the younger population of HTHCM patients, the same as older HTHCM patients, 1 are endangered to a decreased survival rate. A prospective follow-up should be undertaken to clarify this issue.
In conclusion, hypertension associated with HCM is not rare in young patients, and its coincidence significantly increases in older patients. Hypertension overlapping on HCM additionally deteriorates functional status in younger patients whereas the degree of NYHA class increase was comparable between HTHCM and HCM in older patients. In a further study, the potential detrimental influence of hypertension overlapping HCM on survival rate should be studied in a subset of young patients.
